MNPR · ISSUER CIK 1645469
Monopar Therapeutics
Between Aug 1, 2026 and Oct 29, 2026, 7 Monopar Therapeutics insiders reported $0.00 of open-market purchases and $4.0M of sales on SEC Form 4.
↗7 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 5 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$4.0MInsider selling
−$4.0MNet open-market
Oct 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202616:59 | Oct 20, 2026 | MNPR | Chief Executive Officer, Director | F · Tax | $92.59 | −597 | 104,127 | -1% | $55K | ||
| Oct 5, 202617:43 | Oct 1, 2026 | MNPR | Director | S · Sell10b5-1 | $78.50 | −8,400 | 5,173 | -62% | −$659K | ||
| Oct 5, 202617:43 | Oct 1, 2026 | MNPR | Director | M · Exercise10b5-1 | $0.01 | +8,400 | 13,573 | +162% | $42.00 | ||
| Oct 2, 202618:15 | Sep 30, 2026 | MNPR | Chief Operating Officer | M · Exercise | — | +4,384 | 59,998 | +8% | — | ||
| Oct 2, 202618:15 | Sep 30, 2026 | MNPR | Chief Operating Officer | F · Tax | $79.67 | −1,944 | 58,054 | -3% | $155K | ||
| Oct 2, 202618:14 | Sep 30, 2026 | MNPR | Chief Executive Officer, Director | M · Exercise | — | +9,801 | 109,068 | +10% | — | ||
| Oct 2, 202618:14 | Sep 30, 2026 | MNPR | Chief Executive Officer, Director | F · Tax | $79.67 | −4,344 | 104,724 | -4% | $346K | ||
| Oct 2, 202618:14 | Sep 30, 2026 | MNPR | Chief Financial Officer | M · Exercise | — | +614 | 2,835 | +28% | — | ||
| Oct 2, 202618:14 | Sep 30, 2026 | MNPR | Chief Financial Officer | F · Tax | $79.67 | −180 | 2,655 | -6% | $14K | ||
| Sep 28, 202620:47 | Sep 24, 2026 | MNPR | Chief Executive Officer, Director | S · Sell10b5-1 | $88.00 | −29,056 | 99,267 | -23% | −$2.6M | ||
| Sep 28, 202620:47 | Sep 24, 2026 | MNPR | Chief Executive Officer, Director | M · Exercise10b5-1 | $21.74 | +29,056 | 128,323 | +29% | $632K | ||
| Aug 27, 202619:29 | Aug 26, 2026 | MNPR | Acting Chief Medical Officer | S · Sell10b5-1 | $111.26 | −1 | 5,065 | -0% | −$111.26 | ||
| Aug 27, 202619:29 | Aug 26, 2026 | MNPR | Acting Chief Medical Officer | M · Exercise10b5-1 | $0.01 | +1,380 | 5,066 | +37% | $6.90 | ||
| Aug 27, 202618:28 | Aug 26, 2026 | MNPR | Director | S · Sell10b5-1 | $111.39 | −4,090 | 7,396 | -36% | −$456K | ||
| Aug 27, 202618:27 | Aug 25, 2026 | MNPR | Director | S · Sell10b5-1 | $111.77 | −3,142 | 23,751 | -12% | −$351K |